The pharmaceutical industry has long used speakers bureaus and their associated meetings and events to educate healthcare providers (HCPs) about drug therapies and the diseases those drugs treat. However, while the value of a speakers bureaus is clear, the practice has been, at times, misused. Industry players must be deliberate with a keen eye on compliance when leveraging this powerful to build their brands . . .
Technological and cultural forces are shifting the expectations that patients bring to their healthcare. Armed with the ever-growing availability of information (and misinformation) on the